Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Bernard Fritzell"'
Autor:
Johan Vekemans, Beatrice De Vos, Bernard Fritzell, Mark Hatherill, Michael Brennan, Georges Thiry, Matteo Zignol, Kathryn Tucker Rutkowski, Lewis K Schrager, Barry Walker, Ann M. Ginsberg
Publikováno v:
Vaccine. 38:135-142
Treating tuberculosis (TB) requires a multidrug course of treatment lasting 6 months, or longer for drug-resistant TB, which is difficult to complete and often not well tolerated. Treatment failure and recurrence after end-of-treatment can have devas
Autor:
Dominick Laddy, Gerald Voss, Dereck Tait, Ilona van den Brink, Marit Holleman, Maria Lempicki, Danielle Roordink, Leo van der Pol, Ann Williams, Anne Marie Graffin, Emmanuelle Gerdil, Jelle Thole, Bernard Fritzell, Georges Thiry
Publikováno v:
Tuberculosis (Edinburgh, Scotland)
Two proof of concept clinical trials with TB vaccines demonstrate that new approaches can prevent sustained TB infection in adolescents (BCG revaccination) and TB disease in adults (M72/ASO1E) (Nemes et al., 2018; Tait et al., 2019) [1,2]. Both appro
Autor:
Xoliswa Kalepu, Lebohang Makhethe, Simbarashe Mabwe, Tim Reid, Susan Rossouw, Petrus Tyambethu, Juana Doce, Fazlin Kafaar, Adam Penn-Nicholson, Nondumiso Khomba, Lungisa Jack, Helen Mearns, Nicole Bilek, Angelique Kany Kany Luabeya, Yolande Gregg, Ingrid Murillo, Elma Van Rooyen, Julia Noble, Erica Smit, Constance Schreuder, Nacho Aguilo, Michele Tameris, Jesús Gonzalo-Asensio, Humphrey Mulenga, Munyaradzi Musvosvi, Yolundi Cloete, Natasja Botes, Esteban M. Rodríguez, Hadn Africa, Bernard Fritzell, Jelle Thole, Mark Hatherill, Thomas J. Scriba, Eugenia Puentes, Margaret Erasmus, Ashley Veldsman, Marwou de Kock, Angelique Mouton, Hennie Geldenhuys, Sandra Kruger, Fajwa Opperman, Justin Shenje, Marcia Steyn, Carlos Martin, Denis Arendsen, Dessislava Marinova, Thelma Leopeng
Publikováno v:
The Lancet. Respiratory medicine. 7(9)
Summary Background Infants are a key target population for new tuberculosis vaccines. We assessed the safety and immunogenicity of the live-attenuated Mycobacterium tuberculosis vaccine candidate MTBVAC in adults and infants in a region where transmi
Autor:
Birgitte K. Giersing, Kayvon Modjarrad, David C. Kaslow, Vasee S. Moorthy, Ashish Bavdekar, Klaus Cichutek, Alejandro Cravioto, Bernard Fritzell, Barney S. Graham, Ruth Karron, Claudio F. Lanata, Mair Powell, Yiming Shao, Peter Smith
Publikováno v:
Vaccine
Highlights • The RTS,S Plasmodium falciparum malaria vaccine has received a positive regulatory assessment by EMA. • The CYD-TDV dengue vaccine has been licensed in some middle-income countries. • A Phase 3 HIV vaccine trial is due to be initia
Publikováno v:
Biologicals. 44:37-50
An international workshop to discuss the role of Human Challenge Trials (HCT) in vaccine development was held in Strasbourg, France from 29 September to 1 October 2015. In addition to scientific presentations, several panel discussions focused on key
Autor:
Paul-Henri Lambert, Padmapriyadarsini Chandrasekaran, Bernard Fritzell, Mark Hatherill, Nadia Tornieporth, Johan Vekemans, Helen McShane, Lewis K Schrager
Publikováno v:
Lancet Infectious Diseases. 18(8)
Autor:
Hana Golding, Pieter Neels, Béatris Mastelic, Bernard Fritzell, Marion F. Gruber, Nathalie Garçon, Giuseppe Del Giudice
Publikováno v:
Biologicals. 41:458-468
Vaccination represents one of the greatest public health triumphs; in part due to the effect of adjuvants that have been included in vaccine preparations to boost the immune responses through different mechanisms. Although a variety of novel adjuvant
Publikováno v:
New Generation Vaccines ISBN: 9780429130090
In the EU, the heterogeneity of vaccination schedules has arisen for essentially historical reasons. In the past, vaccines were registered in an individual country according to licensing requirements that might vary substantially from country to coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6856cf5043d150818757c80d5e4fec86
https://doi.org/10.3109/9781420060744-45
https://doi.org/10.3109/9781420060744-45
Publikováno v:
Vaccine. 30:2728-2737
Streptococcus pneumoniae (SP) causes significant burden of disease, including invasive pneumococcal disease and noninvasive diseases such as pneumonia and acute otitis media. SP has at least 93 different capsular serotypes, with the various serotypes
Autor:
Mark A. Fletcher, Bernard Fritzell
Publikováno v:
Expert Review of Vaccines. 10:263-290
The 7-valent pneumococcal polysaccharide-protein (CRM(197)) conjugate vaccine (PCV-7) was licensed based on clinical efficacy trials using the four-dose schedule of three infant doses and a booster dose in the second year of life (3 + 1). An assessme